Delivery details +
Order by fax
Incyte Corporation - Pharmaceuticals & Healthcare
- PDF: Delivered by email usually within 12 to 24 UK business hours.
Incyte Corporation - Pharmaceuticals & Healthcare
Deals and Alliances Profile
- Product Code:GMD12438
- Publication Date:July 2009
- Publisher:Global Markets Direct
- Product Type: Report
- Pages:23
Incyte Corporation - Pharmaceuticals & Healthcare Deals and Alliances Profile
Incyte Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Incyte Corporation (Incyte) is engaged in discovery and development of small molecule drugs to treat serious unmet medical needs in the field of oncology, inflammation, diabetes and human immunodeficiency virus (HIV). Its products include INCB18424, INCB28050, INCB13739, INCB7839 for Inflammation, Hematologic Malignancies, and Solid Tumors; INCB28060, INCB24360 for treatment of cancer; INCB19602 for type 2 diabetes; INCB9471 and INCB15050 for treatment of HIV. The company is headquartered in Wilmington in Delaware, United States.
Global Market Direct's Incyte Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Table Of Contents
Table Of Contents 2
List of Tables 3
List of Figures 3
Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Incyte Corporation, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7
Incyte Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Incyte Corporation, Pharmaceuticals & Healthcare, Deal Details 9
Incyte Completes Private Placement Of $10 Million 9
Incyte Completes Private Placement Of $151.8 Million 10
Incyte Completes Private Placement Of Convertible Notes $10 Million 11
Incyte Completes Private Placement Of $250 Million 12
Divestiture - Company 13
Agilent Technologies Acquires Velocity11 13
Equity Offering 14
Incyte Completes Public Offering Of $108.67 Million 14
Genomic Health Completes Private Placement Of $5 Million 15
Incyte Completes Public Offering Of $87.75 Million 16
Partnerships 17
Incyte Enters Into An Agreement With Pfizer 17
Incyte Enteres Into An Agreement With Roche Diagnostics 18
Venture Financing 19
diaDexus Secures $20 Million In Series D Funding 19
Key Competitors 21
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About Global Markets Direct 23
Contact Us 23
Disclaimer 23
List of Tables
Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Incyte Corporation, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Incyte Corporation, Deals By Sector, 2004 to YTD 2009 7
Incyte Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Incyte Completes Private Placement Of $10 Million 9
Incyte Completes Private Placement Of $151.8 Million 10
Incyte Completes Private Placement Of Convertible Notes $10 Million 11
Incyte Completes Private Placement Of $250 Million 12
Agilent Technologies Acquires Velocity11 13
Incyte Completes Public Offering Of $108.67 Million 14
Genomic Health Completes Private Placement Of $5 Million 15
Incyte Completes Public Offering Of $87.75 Million 16
Incyte Enters Into An Agreement With Pfizer 17
Incyte Enteres Into An Agreement With Roche Diagnostics 18
diaDexus Secures $20 Million In Series D Funding 19
Incyte Corporation, Key Employees 21
Incyte Corporation, Subsidiaries 22
List of Figures
Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Incyte Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5
Incyte Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Incyte Corporation, Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7
